BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31727206)

  • 1. Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.
    Dukaew N; Konishi T; Chairatvit K; Autsavapromporn N; Soonthornchareonnon N; Wongnoppavich A
    Oncol Res; 2020 Mar; 28(2):161-175. PubMed ID: 31727206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.
    Dukaew N; Chairatvit K; Pitchakarn P; Imsumran A; Karinchai J; Tuntiwechapikul W; Wongnoppavich A
    Oncol Rep; 2020 Oct; 44(4):1441-1454. PubMed ID: 32945500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
    Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
    Liu B; Chen W; Li H; Li F; Jin X; Li Q
    Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines.
    Sak A; Groneberg M; Stuschke M
    Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation.
    Zhang T; Cui GB; Zhang J; Zhang F; Zhou YA; Jiang T; Li XF
    Oncol Rep; 2010 Dec; 24(6):1683-9. PubMed ID: 21042768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of radiosensitization by YM155, a novel small molecule inhibitor of survivin expression, is associated with DNA damage repair.
    Hu S; Fu S; Xu X; Chen L; Xu J; Li B; Qu Y; Yu H; Lu S; Li W
    Cell Physiol Biochem; 2015; 37(3):1219-30. PubMed ID: 26418254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase.
    Zhao Y; Jiang W; Li B; Yao Q; Dong J; Cen Y; Pan X; Li J; Zheng J; Pang X; Zhou H
    Int Immunopharmacol; 2011 Dec; 11(12):2039-46. PubMed ID: 21907831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanyang Xuedai enhances the radiosensitivity of human non-small cell lung cancer cells via increasing iNOS/NO production.
    Wang L; Xia Y; Chen T; Zeng Y; Li L; Hou Y; Li W; Liu Z
    Biomed Pharmacother; 2018 Jun; 102():618-625. PubMed ID: 29602129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.
    Wang J; Chang L; Lai X; Li X; Wang Z; Huang Z; Huang J; Zhang G
    Cell Cycle; 2018; 17(6):671-680. PubMed ID: 29285984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo.
    Kwon SJ; Lee SK; Na J; Lee SA; Lee HS; Park JH; Chung JK; Youn H; Kwon J
    Mol Cancer Ther; 2015 Feb; 14(2):597-607. PubMed ID: 25504753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair.
    Sunada S; Kanai H; Lee Y; Yasuda T; Hirakawa H; Liu C; Fujimori A; Uesaka M; Okayasu R
    Cancer Sci; 2016 Sep; 107(9):1250-5. PubMed ID: 27341700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks.
    Dong J; Zhang T; Ren Y; Wang Z; Ling CC; He F; Li GC; Wang C; Wen B
    Oncotarget; 2017 Apr; 8(14):22662-22673. PubMed ID: 28186989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of G2/M Cell Cycle Arrest via p38/p21
    Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.
    Xu JY; Lu S; Xu XY; Hu SL; Li B; Qi RX; Chen L; Chang JY
    Asian Pac J Cancer Prev; 2015; 16(8):3301-6. PubMed ID: 25921135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
    Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB
    Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
    Toulany M; Kehlbach R; Florczak U; Sak A; Wang S; Chen J; Lobrich M; Rodemann HP
    Mol Cancer Ther; 2008 Jul; 7(7):1772-81. PubMed ID: 18644989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.
    Zou N; Xie G; Cui T; Srivastava AK; Qu M; Yang L; Wei S; Zheng Y; Wang QE
    Tumour Biol; 2016 Oct; 37(10):14183-14191. PubMed ID: 27553023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
    Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
    Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.